A modular approach to the ECVAM principles on test validity

被引:259
作者
Hartung, T [1 ]
Bremer, S [1 ]
Casati, S [1 ]
Coecke, S [1 ]
Corvi, R [1 ]
Fortaner, S [1 ]
Gribaldo, L [1 ]
Halder, M [1 ]
Hoffmann, S [1 ]
Roi, AJ [1 ]
Prieto, P [1 ]
Sabbioni, E [1 ]
Scott, L [1 ]
Worth, A [1 ]
Zuang, V [1 ]
机构
[1] European Commiss, Joint Res Ctr, ECVAM, Inst Hlth & Consumer Protect, Ispra, Italy
来源
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 2004年 / 32卷 / 05期
关键词
in silico; in vitro; in vivo; modular approach; QSARs; test validity validation;
D O I
10.1177/026119290403200503
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The European Centre for the Validation of Alternative Methods (ECVAM) proposes to make the validation process more flexible, while maintaining its high standards. The various aspects of validation are broken down into independent modules, and the information necessary to complete each module is defined. The data required to assess test validity in an independent peer review, not the process, are thus emphasised. Once the information to satisfy all the modules is complete, the test can enter the peer-review process. In this way, the between-laboratory variability and predictive capacity of a test can be assessed independently. Thinking in terms of validity principles will broaden the applicability of the validation process to a variety of tests and procedures, including the generation of new tests, new technologies (for example, genomics, proteomics), computer-based models (for example, quantitative structure-activity relationship models), and expert systems. This proposal also aims to take into account existing information, defining this as retrospective validation, in contrast to a prospective validation study, which has been the predominant approach to date. This will permit the assessment of test validity by completing the missing information via the relevant validation procedure: prospective validation, retrospective validation, catch-up validation, or a combination of these procedures.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 12 条
[1]
[Anonymous], 2003, NIH PUBLICATION
[2]
[Anonymous], 1996, CPMPICH28195
[3]
BALLS M, 1990, ATLA-ALTERN LAB ANIM, V18, P313
[4]
Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P884
[5]
BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
[6]
Balls M, 1997, ATLA-ALTERN LAB ANIM, V25, P483
[7]
CURREN RD, 1995, ATLA-ALTERN LAB ANIM, V23, P211
[8]
ECVAM's response to the changing political environment for alternatives: Consequences of the European Union chemicals and cosmetics policies [J].
Hartung, T ;
Bremer, S ;
Casati, S ;
Coecke, S ;
Corvi, R ;
Fortaner, S ;
Gribaldo, L ;
Halder, M ;
Roi, AJ ;
Prieto, P ;
Sabbioni, E ;
Worth, A ;
Zuang, V .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2003, 31 (05) :473-481
[9]
Good cell culture practice - ECVAM Good Cell Culture Practice Task Force report 1 [J].
Hartung, T ;
Ball, M ;
Bardouille, C ;
Blanck, O ;
Coecke, S ;
Gstraunthaler, G ;
Levvis, D .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2002, 30 (04) :407-414
[10]
The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing [J].
Liebsch, M ;
Traue, D ;
Barrabas, C ;
Spielmann, H ;
Uphill, P ;
Wilkins, S ;
McPherson, JP ;
Wiemann, C ;
Kaufmann, T ;
Remmele, M ;
Holzhütter, HG .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2000, 28 (03) :371-401